Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease

被引:13
|
作者
Sato-Maeda, Mika [1 ]
Fujimura, Miki [1 ]
Kanoke, Atsushi [1 ]
Morita-Fujimura, Yuiko [2 ]
Niizuma, Kuniyasu [1 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Inst Aging & Canc, Dept Mol Biol, Sendai, Miyagi 9808574, Japan
关键词
Moyamoya disease; RNF213; gene; In situ RNA hybridization; Transient focal cerebral ischemia (tFCI); MAGNETIC-RESONANCE ANGIOGRAPHY; LACKING RNF213; TEMPORAL PROFILE;
D O I
10.1016/j.brainres.2015.10.055
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although recent genome-wide and locus-specific association studies revealed that the RING finger protein 213 (RNF213) gene is an important susceptibility gene for moyamoya disease (MMD), the exact mechanism by which the genetic alteration of RNF213 contributes to the development of MMD has not yet been elucidated. A quantitative reverse transcription polymerase chain reaction (PCR) analysis revealed that the constitutive expression of the RNF213 gene was very low in adult and embryonic brain tissue. However, information regarding the temporal and spatial expression patterns of the RNF213 gene under the condition of cerebral ischemia, which is one of characteristic pathologies associated with MMD, is currently limited. In order to address this critical issue, Rnf213 mRNA expression was investigated in mouse brains subjected to 60 min of transient middle cerebral artery occlusion (tMCAO). Male C57BL6/j mice underwent tMCAO through the intraluminal blockade of MCA. Expression of the Rnf213 gene in the tMCAO brain was investigated with in situ RNA hybridization and a real-time PCR analysis from 1 to 72 h after tMCAO. In situ RNA hybridization revealed a significant increase in Rnf213 mRNA levels in the cerebral cortex supplied by the affected MCA, especially at the penumbra area, as early as 6 h after tMCAO, and these levels had increased further by 24 h. Rnf213 gene expression remained unchanged in the non-ischemic hemisphere or control specimens. Double staining of Rnf213 mRNA with NeuN immunohistochemisty revealed Rnf213 hybridization signal expression mostly in neurons. The real-time PCR analysis confirmed induction of the Rnf213 gene after tMCAO. Therefore, the Rnf213 gene was up-regulated in the ischemic brain, especially at the penumbra area, 6 h after tMCAO. Early increases in RNF213 gene expression in neurons after tMCAO indicate its involvement in cerebral ischemia, which is an underlying pathology of MMD. Further investigation is required to clarify its exact role in the pathophysiology of MMD. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 46 条
  • [1] Transient Global Cerebral Ischemia Induces RNF213, a Moyamoya Disease Susceptibility Gene, in Vulnerable Neurons of the Rat Hippocampus CA1 Subregion and Ischemic Cortex
    Sato-Maeda, Mika
    Fujimura, Miki
    Rashad, Sherif
    Morita-Fujimura, Yuiko
    Niizuma, Kuniyasu
    Sakata, Hiroyuki
    Ikawa, Shuntaro
    Tominaga, Teiji
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (09) : 1904 - 1911
  • [2] Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene
    Fujimura, Miki
    Sonobe, Shinya
    Nishijima, Yasuo
    Niizuma, Kuniyasu
    Sakata, Hiroyuki
    Kure, Shigeo
    Tominaga, Teiji
    JOURNAL OF STROKE, 2014, 16 (02) : 65 - 72
  • [3] RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease
    Sasagasako, Tomoki
    Mineharu, Yohei
    Funaki, Takeshi
    Fushimi, Yasutaka
    Chihara, Hideo
    Park, Silsu
    Nakajima, Kota
    Matsui, Yasuzumi
    Okawa, Masakazu
    Kikuchi, Takayuki
    Arakawa, Yoshiki
    TRANSLATIONAL STROKE RESEARCH, 2024,
  • [4] Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease
    Ito, Akira
    Fujimura, Miki
    Niizuma, Kuniyasu
    Kanoke, Atsushi
    Sakata, Hiroyuki
    Morita-Fujimura, Yuiko
    Kikuchi, Atsuo
    Kure, Shigeo
    Tominaga, Teiji
    BRAIN RESEARCH, 2015, 1594 : 310 - 320
  • [5] Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene
    Sonobe, Shinya
    Fujimura, Miki
    Niizuma, Kuniyasu
    Fujimura, Taku
    Furudate, Sadanori
    Nishijima, Yasuo
    Kure, Shigeo
    Tominaga, Teiji
    NEUROREPORT, 2014, 25 (18) : 1442 - 1446
  • [6] RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
    Zhang, Qian
    Liu, Yaping
    Zhang, Dong
    Wang, Rong
    Zhang, Yan
    Wang, Shuo
    Yu, Lanbing
    Lu, Chaoxia
    Liu, Fang
    Zhou, Jian
    Zhang, Xue
    Zhao, Jizong
    JOURNAL OF NEUROSURGERY, 2017, 126 (04) : 1106 - 1113
  • [7] Aplastic or twig-like middle cerebral artery and cardiogenic cerebral embolism mimicking moyamoya disease with RNF213 polymorphism: A case report
    Inoue, Hiroyasu
    Oomura, Masahiro
    Nishikawa, Yusuke
    Mase, Mitsuhito
    Matsukawa, Noriyuki
    INTERVENTIONAL NEURORADIOLOGY, 2022, 28 (06) : 634 - 638
  • [8] Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review
    Liao, Xin
    Deng, Jing
    Dai, Wenjie
    Zhang, Tong
    Yan, Junxia
    ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, 2017, 22 (01)
  • [9] RNF213 Variant and Infectious Burden Associated With Intracranial Artery Stenosis in Moyamoya Disease
    Zeng, Chaofan
    Ge, Peicong
    Yin, Zihan
    Lu, Junlin
    Yu, Xiaofan
    Li, Junsheng
    Zhai, Yuanren
    Liu, Chenglong
    He, Qiheng
    Liu, Wei
    Wang, Jia
    Liu, Xingju
    Ye, Xun
    Zhang, Qian
    Wang, Rong
    Zhang, Yan
    Zhang, Dong
    Zhao, Jizong
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [10] Characterization of Moyamoya and Middle Cerebral Artery Diseases by Carotid Canal Diameter and RNF213 p.R4810K Genotype
    Oichi, Yuki
    Mineharu, Yohei
    Agawa, Yuji
    Morimoto, Takaaki
    Funaki, Takeshi
    Hitomi, Toshiaki
    Kobayashi, Hatasu
    Todo, Kenichi
    Tani, Shoichi
    Imamura, Hirotoshi
    Yoshida, Kazumichi
    Kataoka, Hiroharu
    Koizumi, Akio
    Sakai, Nobuyuki
    Miyamoto, Susumu
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (06)